RhumbLine Advisers’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Buy |
92,908
+9,681
| +12% | +$209K | ﹤0.01% | 1888 |
|
|
2025
Q1 | $1.9M | Buy |
83,227
+566
| +0.7% | +$12.9K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $2.15M | Sell |
82,661
-357
| -0.4% | -$9.27K | ﹤0.01% | 1847 |
|
|
2024
Q3 | $2.08M | Sell |
83,018
-4,455
| -5% | -$112K | ﹤0.01% | 1892 |
|
|
2024
Q2 | $1.87M | Buy |
87,473
+3,912
| +5% | +$83.8K | ﹤0.01% | 1919 |
|
|
2024
Q1 | $1.55M | Buy |
83,561
+987
| +1% | +$18.3K | ﹤0.01% | 2031 |
|
|
2023
Q4 | $1.34M | Buy |
82,574
+2,207
| +3% | +$35.9K | ﹤0.01% | 2115 |
|
|
2023
Q3 | $1.11M | Buy |
80,367
+116
| +0.1% | +$1.6K | ﹤0.01% | 2146 |
|
|
2023
Q2 | $1.77M | Sell |
80,251
-7,097
| -8% | -$157K | ﹤0.01% | 1978 |
|
|
2023
Q1 | $1.9M | Buy |
87,348
+4,717
| +6% | +$103K | ﹤0.01% | 1832 |
|
|
2022
Q4 | $1.5M | Buy |
82,631
+4,039
| +5% | +$73.5K | ﹤0.01% | 1936 |
|
|
2022
Q3 | $1.79M | Buy |
78,592
+6,480
| +9% | +$147K | ﹤0.01% | 1822 |
|
|
2022
Q2 | $996K | Buy |
72,112
+35,914
| +99% | +$496K | ﹤0.01% | 2147 |
|
|
2022
Q1 | $823K | Sell |
36,198
-15,874
| -30% | -$361K | ﹤0.01% | 2210 |
|
|
2021
Q4 | $1.94M | Sell |
52,072
-7,722
| -13% | -$288K | ﹤0.01% | 1902 |
|
|
2021
Q3 | $2.53M | Buy |
59,794
+36,767
| +160% | +$1.56M | ﹤0.01% | 1763 |
|
|
2021
Q2 | $1.03M | Buy |
23,027
+9,055
| +65% | +$403K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $503K | Buy |
13,972
+335
| +2% | +$12.1K | ﹤0.01% | 2491 |
|
|
2020
Q4 | $544K | Buy |
13,637
+2,525
| +23% | +$101K | ﹤0.01% | 2407 |
|
|
2020
Q3 | $322K | Buy |
+11,112
| New | +$322K | ﹤0.01% | 2483 |
|